In this section
From 1st of April 2021, haemato-oncology genomic testing will align to the NHSE National Genomic Test Directory (NTD) for Cancer.
Standard-of-care testing will be delivered by multiple testing pathways, with consolidation to NGS panel workflows where possible. Parallel whole genome sequencing is also available for some referral types as indicated in the NTD.